Montreal Heart Institute | Zee News

Advertisement

NewsMontreal Heart Institute

Montreal Heart Institute News

31 May 2021

This cheap, oral anti-inflammatory drug can reduce COVID severity

Colchicine could be used to reduce the risk of complications for some patients with COVID-19 The results showed that of 4,159 patients with COVID, the primary endpoint -- that is the composite of death or hospitalisation -- occurred in 4.6 per cent of patients in the colchicine group compared to 6.0 per cent in the placebo group

Loading...

NEWS ON ONE CLICK